Taro Pharmaceutical Industries (NYSE:TARO):
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Taro Pharmaceutical Industries Ltd. (TARO).
The company is down by -3.77 percent from yesterday’s close.
The stock is trading at $102.02 which is slightly below the 50 day moving average of $111.01 and a tad under the 200 day moving average of $132.31. The 50 day moving average was down $-9.00 and the 200 day average was down $-30.29.
The P/E ratio is 7.97 and market capitalization is 4.32B.